A comprehensive protein expression profile of extracellular matrix biomaterial derived from porcine urinary bladder

Regenerative Medicine

Volumn 7, Issue 2, 2012, Pages 159-166

  Maral, Helder ^a   Ahmed, Tania ^a   Badylak, Stephen F ^b,c   Tottey, Stephen ^b   Foster, L John R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

biomaterial; ECM; extracellular matrix; proteomics; scaffold; tissue engineering; tissue regeneration; UBM; urinary bladder matrix

Indexed keywords

ALCOHOL; BIOMATERIAL; PERACETIC ACID; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER MUCOSA; BLADDER MUSCLE; CONTROLLED STUDY; EXPERIMENTAL PIG; EXTRACELLULAR MATRIX; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION TRAP MASS SPECTROMETRY; MALE; NONHUMAN; PHASE SEPARATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGENERATIVE ABILITY; REGENERATIVE MEDICINE; TISSUE ENGINEERING; WOUND HEALING;

ANIMALS; BIOCOMPATIBLE MATERIALS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; MALE; PROTEIN TRANSPORT; PROTEOMICS; SUBCELLULAR FRACTIONS; SUS SCROFA; URINARY BLADDER;

EID: 84858252457     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.12.6     Document Type: Article

References (71)

1. Pradhan, S, Farach-Carson MC. Mining the extracellular matrix for tissue engineering applications. Regen. Med. 6, 961-970 (2010).
2. Wainwright JM, Czajka CA, Patel UB et al. Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng. Part C Methods 16, 525-532 (2010).
3. Ott HC, Matthiesen TS, Goh SK et al. Perfusion-decellularized matrix: using natures platform to engineer a bioartificial heart. Nat. Med. 14, 213-221 (2008). (Pubitemid 351214548)
4. Agrawal V, Brown BN, Beattie AJ, Gilbert TW, Badylak SF. Evidence of innervation following extracellular matrix scaffold-mediated remodeling of muscular tissues. J. Tissue Eng. Regen. Med. 3, 590-600 (2009).
5. Xu R, Boudreau A, Bissell MJ. Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices. Cancer Metastasis Rev. 28, 167-176 (2009).
6. Badylak SF. Naturally occurring scaffold materials. In: Foundations of Regenerative Medicine: Clinical and Therapeutic Applications. Atala A, Lanza R, Thomson JA (Eds). Elsevier, UK, 326-335 (2010).
7. Robinson K, Li J, Mathison M et al. Extracellular matrix scaffold for cardiac repair. Circulation 112, 137-145 (2005).
8. Carson AE, Barker TH. Emerging concepts in engineering extracellular matrix variants for directing cell phenotype. Regen. Med. 4, 593-600 (2009).
9. Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as abiological scaffold material: structure and function. Acta Biomater. 5, 1-13 (2009).
10. Petersen TH, Calle EA, Zhao L et al. Tissue-engineered lungs for in vivo implantation. Science 329, 538-541 (2010).
11. Stankus JJ, Freytes DO, Badylak SF, Wagner WR. Hybrid nanofibrous scaffolds from electrospinning of a synthetic biodegradable elastomer and urinary bladder matrix. J. Biomater. Sci. Polym. Ed. 19, 635-652 (2008). (Pubitemid 351535786)
12. Badylak SF. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl. Immunol. 12, 367-377 (2004). (Pubitemid 38639730)
13. Ruoslahti E. RGD and other recognition sequences for integrins. Ann. Rev. Cell. Dev. Biol. 12, 697-715 (1996). (Pubitemid 26422728)
14. Reing JE, Zhang L, Myers-Irvin J et al. Degradation products of exrtracellular matrix affect migration and proliferation. Tissue Eng. Part A 5, 605-614 (2008).
15. Davis NF, Callanan A, McGuire BB et al. Porcine extracellular matrix scaffolds in reconstructive urology: an ex vivo comparative study of their biomechanical properties. J. Mech. Behav. Biomed. Mater. 4, 375-382 (2011).
16. Freytes DO, Tullius R, Badylak SF. Effect of storage upon material properties of lyophilised porcine extracellular matrix derived from the urinary bladder. J. Biomed. Mater. Res. B Appl. Biomater. 78, 327-333 (2006). (Pubitemid 44167736)
17. Gilbert TW, Stolz D, Biancaniello F, Simmons-Byrd A, Badylak SF. Production and characterisation of ECM powder: implications for tissue engineering applications. Biomaterials 26, 1431-1435 (2005). (Pubitemid 39336520)
18. Dinnes D, Marçal H, Raftery M, Labow R, Mahler S. The macrophage-biomaterial interface: a proteomic analysis of the conditioned medium environment. J. Chem. Technol. Biotechnol. 83, 482-495 (2008). (Pubitemid 351460912)
19. Reing JE, Brown BN, Daly KA et al. The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds. Biomaterials 31, 8626-8633 (2010).
20. Curtis AM, Seo S-B, Westgate EJ et al. Histone acetyltransferase- dependent chromatin remodeling and the vascular clock. J. Biol. Chem. 279, 7091-7097 (2004). (Pubitemid 38248855)
21. Forsberg EC, Downs KM, Christensen HM, Im H, Nuzzi PA, Bresnick EH. Developmentally dynamic histone acetylation pattern of a tissue-specific chromatin domain. Proc. Natl Acad. Sci. USA 97, 14494-14499 (2000). (Pubitemid 32016604)
22. Mitchison TJ, Cramer LP. Actin-based cell motility and cell locomotion. Cell 84, 371-380 (1996).
23. Mogilner A, Oster G. Cell motility driven by actin polymerization. Biophys. J. 71, 3030-3045 (1996). (Pubitemid 26422346)
24. Zhu L, Vranckx R, Van Kien PK et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat. Genet. 38, 343-349 (2006).
25. Peyton SR, Raub CB, Keschrumrus VP, Putnam AJ. The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells. Biomaterials 27, 4881-4893 (2006). (Pubitemid 43866921)
26. Yoshio T, Morita T, Kimura Y, Tsujii M, Hayashi N., Sobue K. Caldesmon suppresses cancer cell invasion by regulating podosome/ invadopodium formation. FEBS Lett. 581, 3777-3782 (2007). (Pubitemid 47102304)
27. Lampe AK, Bushby KMD. Collagen VI related muscle disorders. J. Med. Genet. 42, 673-685 (2005). (Pubitemid 41306057)
28. Bellows CG, Reimers SM, Heersche JNM. Expression of mRNAs for type-I collagen, bone sialoprotein, osteocalcin, and osteopontin at different stages of osteoblastic differentiation and their regulation by 1, 25 dihydroxyvitamin D3. Cell Tissue Res. 297, 249-259 (1999). (Pubitemid 29366470)
29. Syed F, Ahmadi E, Iqbal SA, Singh S, McGrouther DA, Bayat A. Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy. Br. J. Dermatol. 164, 83-96 (2010).
30. Pajala A, Melkko J, Leppilahti J, Ohtonen P, Soini Y, Risteli J. Tenascin-C and type I and III collagen expression in total Achilles tendon rupture. An immunohistochemical study. Histol. Histopathol. 24, 1207-1211 (2009).
31. Lethias C, Descollonges Y, Garrone R, Van der Rest M. Expression of type XIV collagen during the differentiation of fetal bovine skin: immunolabeling with monoclonal antibody is prominent in morphogenetic areas. J. Invest. Dermatol. 101, 92-99 (1993). (Pubitemid 23213019)
32. Young BB, Gordon MK, Birk DE. Expression of type XIV collagen in developing chicken tendons: association with assembly and growth of collagen fibrils. Develop. Dyn. 217, 430-439 (2000). (Pubitemid 30185566)
33. Bornslaeger EA, Corcoran CM, Stappenbeck TS, Green KJ. Breaking the connection: displacement of the desmosomal plaque protein desmoplakin from cell-cell interfaces disrupts anchorage of intermediate filament bundles and alters intercellular junction assembly. J. Cell. Biol. 134, 985-1001 (1996). (Pubitemid 26278223)
34. Meng JJ, Bornslaeger EA, Green KJ, Steinert PM, Ip W. Two-hybrid analysis reveals fundamental differences in direct interactions between desmoplakin and cell type-specific intermediate filaments. J. Biol. Chem. 272, 21495-21503 (1997). (Pubitemid 27374023)
35. Goldoni S, Iozzo RV. Tumor microenvironment: modulation by decorin and related molecules harbouring leucine-rich tandem motifs. Int. J. Cancer 23, 2473-2479 (2008).
36. Nomura Y. Structural change in decorin with skin aging. Connect. Tissue Res. 47, 249-255 (2006). (Pubitemid 44803792)
37. Zhou Z, Wang J, Cao R et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res. 64, 4699-4702 (2004). (Pubitemid 38924508)
38. Zoeller JJ, McQuillan A, Whitelock J, Ho SY, Iozzo RV. A central function for perlecan in skeletal muscle and cardiovascular development. J. Cell. Biol. 181, 381-394 (2008). (Pubitemid 351574560)
39. Boruch AV, Nieponice A, Qureshi IR, Gilbert TW, Badylak SF. Constructive remodeling of biologic scaffolds is dependent on early exposure to physiologic bladder filling in a canine partial cystectomy model. J. Surg. Res. 161, 217-225 (2010).
40. Valentin JE, Turner NJ, Gilbert TW, Badylak SF. Functional skeletal muscle formation with a biologic scaffold. Biomaterials 31, 7475-7484 (2010).
41. Brown BN, Valentin JE, Stewart-Akers AM, McCabe GP, Badylak SF. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 30, 1482-1491 (2009).
42. Cook JL, Tomlinson JL, Arnoczky SP, Fox DB, Cook CR, Kreeger JM. Kinetic study of the replacement of porcine small intestinal submucosa grafts and the regeneration of meniscal-like tissue in large avascular meniscal defects in dogs. Tissue Eng. 7, 321-334 (2001). (Pubitemid 32574930)
43. Gilbert TW, Gilbert S, Madden M, Reynolds SD, Badylak SF. Morphologic assessment of extracellular matrix scaffolds for patch tracheoplasty in a canine model. Ann. Thorac. Surg. 86, 967-974 (2008).
44. Bereczki E, Santha M. The role of biglycan in the heart. Connect. Tissue Res. 49, 129-132 (2008).
45. Kinsella MG, Bressler SL, Wight TN. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit. Rev. Eukaryot. Gene Expr. 14, 203-234 (2004). (Pubitemid 38931846)
46. Norris RA, Moreno-Rodriguez R, Hoffman S, Markwald RR. The many facets of the matricellular protein periostin during cardiac development, remodeling and pathophysiology. J. Cell Commun. Signal. 3, 275-286 (2009).
47. Conway SJ, Molkentin JD. Periostin as a heterofunctional regulator of cardiac development and disease. Curr. Genomics 9, 548-555 (2008).
48. Tombran-Tink J, Barnstable CJ. Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor. Trends Mol. Med. 9, 244-250 (2003). (Pubitemid 36841683)
49. Yamagishi SI, Matsui T. Anti-atherothrombogenic properties of PEDF. Curr. Molec. Med. 10, 284-291 (2010).
50. Yabe T, Sanagi H, Yamada Y. The neuroprotective role of PEDF: implication for the therapy of neurological disorders. Curr. Molec. Med. 10, 259-266 (2010).
51. Shields KJ, Beckman MJ, Bowlin GL, Wayne JS. Mechanical properties and cellular proliferation of electrospun collagen type II. Tissue Eng. 10, 1510-1517 (2004). (Pubitemid 39557854)
52. Chang Y, Chen S, Liang H, Sung H, Lin C, Huang R. The effect of galectin 1 on 3T3 cell proliferation on chitosan membranes. Biomaterials 25, 3603-3611 (2004). (Pubitemid 38327048)
53. Altin JG, Sloan EK. The role of CD45 and CD45-associated molecules in T cell activation. Aust. J. Exp. Biol. Med. Sci. 75, 430-445 (1997). (Pubitemid 27508982)
54. Puche AC, Poirier F, Hair M, Bartlett PF, Key B. Role of galectin-1 in developing mouse olfactory system. Dev Biol, 179, 274-287 (1996). (Pubitemid 26363263)
55. Yang R, Liu F. Galectins in cell growth and apoptosis. Cell. Mol. Life Sci. 60, 267-276 (2003). (Pubitemid 36343907)
56. Hsu DK, Liu FT. Regulation of cellular homeostasis by galectins. Glycoconj. J. 19, 507-515 (2002). (Pubitemid 38316524)
57. Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK, Tzanakakis GN. Lumican, a small leucine-rich proteoglycan. IUBMB Life 60, 818-823 (2008).
58. Kao WYWW, Liu CYCY. Roles of lumican and keratocan on corneal transparency. Glycoconj. J. 19, 275-285 (2002).
59. Saussez S, Kiss R. Galectin-7. Cell. Mol. Life Sci. 63, 686-697 (2006).
60. Kontrogianni-Konstantopoulos A, Catino DH, Strong JC, Randall WR, Bloch RJ. Obscurin regulates the organization of myosin into A bands. Am. J. Physiol. Cell. Physiol. 287, C209-C217 (2004). (Pubitemid 38780169)
61. Mizuno Y, Thompson TG, Guyon JR et al. Desmuslin, an intermediate filament protein that interats with alpha-dystrobrevin and desmin. Proc. Natl Acad. Sci. USA 98, 6156-6161 (2001). (Pubitemid 32488209)
62. Li Z, Mericskay M, Agbulut O et al. Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J. Cell. Biol. 139, 129-144 (1997). (Pubitemid 27444086)
63. Wang N, Stamenovic D. Mechanics of vimentin intermediate filaments. J. Muscle Res. Cell Motil. 23, 535-540 (2002). (Pubitemid 36583670)
64. Freeman LJ, Lomas A, Hodson N et al. Fibulin-5 interacts with fibrillin-1 molecules and microfibrils. Biochem. J. 388, 1-14 (2005).
65. Hirai M, Ohbayashi T, Horiguchi M et al. Fibulin-5/DANCE has an elastogenic organiser activity that is abrogated by proteolytic cleavage in vivo. J. Cell. Biol. 176, 1061-1071 (2007). (Pubitemid 46506977)
66. Lotery AJ, Baas D, Ridley C et al. Reduced secretion of fibulin-5 in age-related macular degeneration and cutis laxa. Human Mutat. 27, 568-574 (2006). (Pubitemid 43865730)
67. Stone EM, Braun TA, Russell SR et al. Missense variations in the fibulin-5 gene and age related macular degeneration. N. Engl. J. Med. 351, 346-353 (2004). (Pubitemid 38944403)
68. Li J, Zhang Y-P, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Micros. Res. Techniq. 60, 107-114 (2003). (Pubitemid 36055239)
69. Concannon CG, Gorman AM, Samali A. On the role of Hsp27 in regulating apoptosis. Apoptosis 8, 61-70 (2003). (Pubitemid 36133139)
70. Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S, Arrigo AP. Hsp27 as a negative regulator of cytochrome C release. Mol. Cell Biol. 22, 816-834 (2002). (Pubitemid 34053061)
71. Wagstaff MJD, Collaço-Moraes Y, Smith J, de Belleroche JS, Coffin RS, Latchman DS. Nucleic acids, protein synthesis, and molecular genetics. J. Biol. Chem. 274, 5061-5069 (1999).